FSMAX
Price
$74.07
Change
-$0.55 (-0.74%)
Updated
Apr 7 closing price
Net Assets
36.55B
LMOPX
Price
$26.78
Change
-$0.08 (-0.30%)
Updated
Apr 7 closing price
Net Assets
1.23B
Ad is loading...

FSMAX vs LMOPX

Header iconFSMAX vs LMOPX Comparison
Open Charts FSMAX vs LMOPXBanner chart's image
Fidelity Extended Market Index
Price$74.07
Change-$0.55 (-0.74%)
VolumeN/A
Net Assets36.55B
Patient Opportunity C
Price$26.78
Change-$0.08 (-0.30%)
VolumeN/A
Net Assets1.23B
FSMAX vs LMOPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMAX vs. LMOPX commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and LMOPX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 36.5B vs. LMOPX (1.23B). FSMAX pays higher dividends than LMOPX: FSMAX (0.53) vs LMOPX (0.00). FSMAX was incepted earlier than LMOPX: FSMAX (14 years) vs LMOPX (25 years). LMOPX (2.53) is less costly to investors than FSMAX (0.04). LMOPX is a more actively managed with annual turnover of: 35.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than LMOPX: FSMAX (0) vs LMOPX (1000). FSMAX (-8.32) and LMOPX (-8.36) have marching annual gain over last year. FSMAX return over 5 years is better than : 62.79 vs. LMOPX (55.98).
FSMAXLMOPXFSMAX / LMOPX
Total Expense Ratio0.042.521%
Annual Report Gross Expense Ratio0.042.531%
Fund Existence14 years25 years-
Gain YTD-17.892-20.46287%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets36.5B1.23B2,970%
Annual Yield % from dividends0.530.00-
Returns for 1 year-8.32-8.36100%
Returns for 3 years1.33-14.54-9%
Returns for 5 years62.7955.98112%
Returns for 10 years39.6636.35109%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDP0.470.01
+2.86%
Indaptus Therapeutics
VTRS7.61-0.01
-0.13%
Viatris
RAPT1.05-0.01
-0.94%
RAPT Therapeutics
USAC23.19-0.41
-1.74%
USA Compression Partners LP
SUPV10.56-0.41
-3.74%
Grupo Supervielle SA